Entrada Therapeutics TRDA
NASDAQ TRDA
$4.63 -0.02 (-0.43%)
As of: Oct 22, 2026 · 12:40 PM EDT

Entrada Therapeutics (TRDA) EV to FCF (2023)

Updated

Entrada Therapeutics' EV to FCF was 3.26 in Q4 2023, down 23.8% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) EV to FCF (2023) Analysis & Trends

From Q1 2023 onward, Entrada Therapeutics has reported EV to FCF for 4 quarters.

  • Quarterly EV to FCF has moved between 2.00 (Q1 2023) and 4.27 (Q3 2023) over five years.
  • Per Business Quant data, TRDA's EV to FCF in the three quarters before Q4 2023 was 4.27 (Q3 2023), 3.89 (Q2 2023) and 2.00 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.90 Bn 1,139.49 Bn 19.71 Bn
2 Johnson & Johnson 643.26 Bn 561.78 Bn 17.26 Bn
3 AbbVie 501.85 Bn 474.96 Bn 12.70 Bn
4 Merck 370.72 Bn 325.10 Bn 12.21 Bn
5 Novartis Ag 302.56 Bn 266.55 Bn 11.24 Bn
6 Astrazeneca 268.35 Bn 242.04 Bn 12.86 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn
8 Gilead Sciences 193.22 Bn 167.42 Bn 6.22 Bn
9 Pfizer 172.25 Bn 118.90 Bn 10.94 Bn
10 Entrada Therapeutics 195.91 Mn -163.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.26
Sep 30, 2023 4.27
Jun 30, 2023 3.89
Mar 31, 2023 2.00
API Access

Entrada Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=TRDA&period=max&api_key=YOUR_API_KEY